Skip to main content
LNAI
NASDAQ Life Sciences

Lunai Bioworks Inks Exclusive Tanaist Deal to Validate Parkinson's Subtypes

Tom Rudovsky · Reported by PR Newswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$2.4
Mkt Cap
$10.428M
52W Low
$1.21
52W High
$15.36
52W Position info
98% above low
Off High info
84% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

LNAI sits 98% above its 52-week low of $1.21 on light trading volume (0.1× avg).

Summary

Lunai Bioworks signed an exclusive worldwide license and collaboration agreement with Tanaist, Inc. to add human cellular phenotyping to its AI-driven Parkinson's disease platform. The deal gives Lunai exclusive rights to Tanaist's technology in Parkinson's for programs based on Lunai's patient phenoclusters, with Lunai owning all collaboration-generated results and IP. This follows Lunai's August 2026 collaboration with BrainStorm Therapeutics, building multiple independent validation paths for its AI-derived disease signals. The agreement is a meaningful step toward validating Lunai's three Parkinson's subtypes and could support biomarker and therapeutic target development, though no financial terms were disclosed. For a micro-cap company with a going concern warning, this partnership adds scientific credibility but does not immediately address its cash burn or dilution concerns.

At the time of this announcement, LNAI was trading at $2.40 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $10.4M. The 52-week trading range was $1.21 to $15.36. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: PR Newswire.


Price Chart

Share this article

Copied!

LNAI - Latest Insights

LNAI
Oct 23, 2026, 2:21 AM EDT
Source: Seeking Alpha
Importance Score:
9
Price at Filing: $0.380
Real-time Price: $0.091 info
Change: -$0.289 (-76%) info
Market Cap: $829.678K info
LNAI
Oct 22, 2026, 9:38 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.3111
Real-time Price: $0.091 info
Change: -$0.2201 (-71%) info
Market Cap: $829.678K info
LNAI
Oct 13, 2026, 4:55 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $1.04
Real-time Price: $0.091 info
Change: -$0.949 (-91%) info
Market Cap: $829.678K info
LNAI
Oct 09, 2026, 2:00 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.18
Real-time Price: $0.091 info
Change: -$1.08 (-92%) info
Market Cap: $829.678K info
LNAI
Aug 04, 2026, 3:28 PM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $2.54
Real-time Price: $0.091 info
Change: -$2.45 (-96%) info
Market Cap: $829.678K info